Kai-oliver Henrich

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas.

High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas.

Journal: Cell death & disease
Published: November 01, 2024

Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome.

Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome.

Journal: Nature genetics
Published: July 04, 2022

In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.

In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.

Journal: Leukemia
Published: March 22, 2022

Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma.

Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma.

Journal: British journal of cancer
Published: September 15, 2021

MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis.

MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis.

Journal: Nature cancer
Published: August 13, 2021

FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome.

FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 10, 2021

Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation.

Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation.

Journal: Cancers
Published: October 15, 2020

Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome.

Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome.

Journal: Nature communications
Published: May 19, 2020

Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.

Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.

Journal: Nature genetics
Published: May 04, 2020

Super enhancers define regulatory subtypes and cell identity in neuroblastoma.

Super enhancers define regulatory subtypes and cell identity in neuroblastoma.

Journal: Nature cancer
Published: September 11, 2019

Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma.

Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma.

Journal: Life science alliance
Published: February 04, 2019

Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.

Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.

Journal: Cellular and molecular life sciences : CMLS
Published: October 01, 2018
Showing 1-12 of 26

Last Updated: 09/26/2026